<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Integr Pharm Res Pract</journal-id><journal-id journal-id-type="iso-abbrev">Integr Pharm Res Pract</journal-id><journal-id journal-id-type="publisher-id">Integrated Pharmacy Research and Practice</journal-id><journal-title-group><journal-title>Integrated Pharmacy Research &#x00026; Practice</journal-title></journal-title-group><issn pub-type="epub">2230-5254</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29354536</article-id><article-id pub-id-type="pmc">5741035</article-id><article-id pub-id-type="doi">10.2147/IPRP.S100336</article-id><article-id pub-id-type="publisher-id">iprp-5-027</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Community pharmacists provided telephone treatment support for patients who received long-term prescribed medication</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Nobuo</given-names></name><xref ref-type="aff" rid="af1-iprp-5-027">1</xref></contrib><contrib contrib-type="author"><name><surname>Nitta</surname><given-names>Mitsuyo</given-names></name><xref ref-type="aff" rid="af1-iprp-5-027">1</xref></contrib><contrib contrib-type="author"><name><surname>Kamei</surname><given-names>Miwako</given-names></name><xref ref-type="aff" rid="af2-iprp-5-027">2</xref><xref ref-type="corresp" rid="c1-iprp-5-027"/></contrib><contrib contrib-type="author"><name><surname>Hara</surname><given-names>Kazuo</given-names></name><xref ref-type="aff" rid="af1-iprp-5-027">1</xref></contrib><contrib contrib-type="author"><name><surname>Watanabe</surname><given-names>Fumiyuki</given-names></name><xref ref-type="aff" rid="af2-iprp-5-027">2</xref></contrib><contrib contrib-type="author"><name><surname>Akagawa</surname><given-names>Keiko</given-names></name><xref ref-type="aff" rid="af1-iprp-5-027">1</xref></contrib><contrib contrib-type="author"><name><surname>Kurata</surname><given-names>Naomi</given-names></name><xref ref-type="aff" rid="af1-iprp-5-027">1</xref></contrib></contrib-group><aff id="af1-iprp-5-027">
<label>1</label>Division of Community Healthcare and Pharmacy, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan</aff><aff id="af2-iprp-5-027">
<label>2</label>Division of Health Communication, School of Pharmacy, Nihon University, Chiba, Japan</aff><author-notes><corresp id="c1-iprp-5-027">Correspondence: Miwako Kamei, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi, Chiba 274-8555, Japan, Tel +81 47 464 2111, Email <email>kamei.miwako@nihon-u.ac.jp</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>29</day><month>3</month><year>2016</year></pub-date><volume>5</volume><fpage>27</fpage><lpage>32</lpage><permissions><copyright-statement>&#x000a9; 2016 Yamamoto et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2016</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>This study was conducted to evaluate whether a community pharmacist&#x02019;s assistance during the treatment of a patient with a chronic illness would help to discover and improve issues regarding the treatment.</p></sec><sec><title>Method</title><p>We employed a prospective intervention study with a control group. The patients ranging in age from 60 to 74, were using one of the six selected community pharmacies in the Tokyo metropolitan area. They had been prescribed six or fewer kinds of medications, one of which was amlodipine. The medication dosages covered 1 month or longer. Patients who agreed to participate in the study were randomly assigned to the groups at each pharmacy. For the patients in the intervention group, the pharmacists provided telephone counseling between physician visits, in addition to the time they visited the pharmacies to collect their medications. For the patients in the control group, the pharmacists provided counseling only at their pharmacies.</p></sec><sec><title>Results and discussion</title><p>The average days of medication administration were 49.2 days for the 58 patients in the intervention group, and 49.8 days for the 53 patients in the control group, with the average number of medications being 3.4 items per person for both groups. Through the telephone counseling, we were able to collect more information, eg, changes in physical condition and occurrences of side effects, from the intervention group than from the control group. The rate of incident detection in the information from the intervention group was five times that of the control group, making subsequent incident resolutions faster.</p></sec><sec><title>Conclusion</title><p>This study suggested that phone counseling between physician visits could enable the identification of more issues regarding patients&#x02019; conditions.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>community pharmacy</kwd><kwd>outpatient</kwd><kwd>long-term dosage</kwd><kwd>telephone assistance</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Under the national health care system in Japan, physicians were only allowed to prescribe medications covering a maximum of either 14 or 30 days, except for medications for epilepsy and thyroid hormones, for which the maximum was 90 days.<xref rid="b1-iprp-5-027" ref-type="bibr">1</xref> In April 2002, this restriction on the length of prescriptions was removed, allowing longer-term prescriptions.<xref rid="b2-iprp-5-027" ref-type="bibr">2</xref> Consequently, the length of prescriptions continued to become longer to this day, 12 years later.<xref rid="b3-iprp-5-027" ref-type="bibr">3</xref> Currently, the Japanese system does not allow prescription refills. When pharmacists in Japan fill a prescription, they generally dispense for the entire prescription period at the same time. To dispense only part of a prescription, a reason related to the quality management of the medication and the patient&#x02019;s agreement are required. If there are no quality-related issues, the entire prescription amount is given to the patient, eg, 180 days&#x02019; worth of medication is given if the medication was prescribed for a 180-day period.</p><p>Although longer-term prescriptions may alleviate patient crowding in medical institutions and the burden on the physician, as well as alleviating the burden on the patient collecting their medications at the hospital, they result in more difficulty in ascertaining the condition of the patient during the prescription period, with the possibility of decreased quality of care due to health changes or misadministration, and of an increased number of unused prescriptions.<xref rid="b4-iprp-5-027" ref-type="bibr">4</xref>&#x02013;<xref rid="b7-iprp-5-027" ref-type="bibr">7</xref> A 2010 Japan Medical Association survey carried out on physicians cited reports of delays in physicians&#x02019; discovery of changes in the patient&#x02019;s health due to long-term prescriptions, cases of acute exacerbation and growing severity, and elderly patients who endured declining health conditions during a long-term prescription.<xref rid="b8-iprp-5-027" ref-type="bibr">8</xref></p><p>When handing dispensed medications to their patients, pharmacists are required to collect information from the patients and provide them with information regarding the proper use of the medications.<xref rid="b9-iprp-5-027" ref-type="bibr">9</xref> However, patients come to the pharmacy after having waited for a long time to be seen by their physicians. Thus, patients are often reluctant to wait again at the pharmacy, resulting in insufficient interaction.</p><p>To address the various issues that long-term prescriptions entail, a pilot study was conducted, in which treatment assistance during the prescription period was selected from: 1) split dispensing (partial prescription filling), 2) house calls, and 3) telephone calls.<xref rid="b10-iprp-5-027" ref-type="bibr">10</xref> The study suggested that regular involvement of the pharmacist provides benefits in terms of the usefulness and safety of pharmacotherapy. Reports from other countries suggest telephone counseling and early intervention by the pharmacist improve adherence and effectively reduce medical expenses,<xref rid="b11-iprp-5-027" ref-type="bibr">11</xref> and that telephone counseling by the pharmacist improves cardiovascular disease patient compliance and reduces the mortality rate.<xref rid="b12-iprp-5-027" ref-type="bibr">12</xref></p><p>In this study, community pharmacists provided medication assistance by telephone to patients taking amlodipine, which is known to be administered to many patients on a long-term basis. Data were collected and sorted and issues to be resolved were identified, while the effectiveness of the pharmacists&#x02019; treatment assistance during the prescription period was evaluated.</p></sec><sec sec-type="methods"><title>Methods</title><sec sec-type="methods"><title>Study design and setting</title><p>This was a prospective intervention study with a control group. The study protocol was approved by the research ethics committee of Showa University. Six community pharmacies in the Tokyo metropolitan area of Japan participated in the study. Participants were patients who visited one of the participating stores in September 2010 and who:
<list list-type="order"><list-item><p>were hypertension patients between the ages of 60 and 74;</p></list-item><list-item><p>were prescribed six or fewer medications including amlodipine;</p></list-item><list-item><p>had 28 days of prescription or longer;</p></list-item><list-item><p>agreed to telephone counseling;</p></list-item><list-item><p>agreed to participate in the study.</p></list-item></list></p><p>Participating pharmacies managed patient information on a closed online network. Names of patients who met the inclusion criteria appeared on the store computer, making them candidates for recruitment. Patients who agreed to participate in the study were automatically and randomly assigned to the groups at each pharmacy using the minimization method, based on age (60s and 70s), sex, and number of prescribed medications (one to three; and four to six). The study period was from July 2010 to January 2011, with each case starting after the patient gave written informed consent.</p></sec><sec><title>Intervention</title><p>A total of seven pharmacists provided counseling. They were selected from those who had had at least 3 years of experience at their pharmacies and consented to participate in this study.</p><p>In the intervention group, a pharmacist called the patient at home for counseling once between two physician visits. If the interval between physician visits exceeded 2 months, telephone counseling was provided once a month. The same support for medication administration was provided for both groups when they visited the pharmacy.</p><p>The pharmacist who provided counseling recorded all patient information in the same format in compliance with the procedure manual of this study. Recorded items totaled eleven: blood pressure; changes in physical condition; side effects; medication administration; quality change in unused medications; visits to physicians of other specialties; concomitant medications; over-the-counter medication; medication interactions; changes in lifestyle; and other (<xref ref-type="table" rid="t1-iprp-5-027">Table 1</xref>).</p></sec><sec><title>Measurement of outcomes</title><p>The follow-up period was 4 months for each patient. After this period, we counted the number of items recorded using the records obtained from counseling, the number of items with incidents, and the number of items whose incidents had been resolved. We also conducted a survey using a self-completed questionnaire to measure changes in the awareness and behavior compared to 4 months earlier.</p></sec><sec sec-type="methods"><title>Data analysis</title><p>Patient characteristics, the number of counseling sessions, the number of items recorded, the number of items with incidents, and the number of items whose incidents had been resolved were tallied up, categorized by counseling given at the pharmacy and by telephone, after which we compared the results between the two groups. The intention to treat method was used for the analysis. The Student&#x02019;s <italic>t</italic>-test and &#x003c7;<sup>2</sup> test were used to determine significance in differences.</p></sec></sec><sec sec-type="results"><title>Results</title><sec sec-type="methods|subjects"><title>Attributes of study participants</title><p>The control group consisted of 53 participants, and the intervention group 59 participants. The average age was 67.6&#x000b1;4.3 for the control group, and 66.9&#x000b1;3.9 for the intervention group. The average initial prescription period per prescription for the control group was 61.3&#x000b1;23.2 days (maximum 180 days), and the intervention group 56.9&#x000b1;23.3 days (maximum 104 days) (<xref ref-type="table" rid="t2-iprp-5-027">Table 2</xref>).</p><p>The control group had two withdrawals. The intervention group had two withdrawals from telephone counseling, one hospital transfer, and one withdrawal due to use of more than one pharmacy.</p></sec><sec><title>Number of counseling sessions</title><p>The average number of times the pharmacists provided treatment assistance to the participants was 2.9 times per person for the control group and 4.8 times per person for the intervention group. The control group received treatment assistance only when they visited the pharmacy to fill a prescription, whereas the intervention group additionally received telephone counseling (1.9 times per participant).</p></sec><sec sec-type="methods"><title>Data collection</title><p>The number of data items collected from counseling is shown in <xref ref-type="table" rid="t3-iprp-5-027">Table 3</xref>. For the control group, the number of counseling sessions conducted at the pharmacy was 837 (15.8 per person), and 935 for the intervention group (57.9% or 15.8 per person). Additionally, the intervention group received 680 telephone counseling sessions (42.1% or 11.5 per person). Seventy to 80% of the collected data were only recorded without any action. However, the intervention group, who also received counseling by telephone, received nearly three times as much counseling as the control group.</p></sec><sec><title>Issues and actions (counseling)</title><p><xref ref-type="table" rid="t4-iprp-5-027">Table 4</xref> shows the incidents with priority needs, eg, high urgency and/or importance. The number of items with these incidents was nine (5.7%) for the control group, whereas it was 46 (10.2%), including 37 (8.2%) by phone counseling, for the intervention group, representing approximately five times as many as that of the control group. The number of items whose incidents had been resolved during the 4-month follow-up period was three (1.9%) for the control group and 25 (5.6%) for the intervention group. <xref ref-type="table" rid="t5-iprp-5-027">Table 5</xref> shows the breakdown of the assistance for issues with high priority and the numbers of incidents verified as resolved.</p></sec><sec><title>Changes in attitude and behavior</title><p>One of the questions in the questionnaire asked about any changes in the patient&#x02019;s attitude and behavior between the start of the study and the time of evaluation. The responses are shown in <xref ref-type="table" rid="t6-iprp-5-027">Table 6</xref>. Only &#x0201c;have a higher desire for treatment&#x0201d; scored higher in the intervention group.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>This study was conducted on elderly patients taking amlodipine, including its generics, which are commonly used for long-term prescriptions. A 2011 national survey by the Ministry of Health, Labour and Welfare indicates a higher prevalence of hypertension in the population of 60 years and older and there are approximately 1.9 million patients with hypertension.<xref rid="b13-iprp-5-027" ref-type="bibr">13</xref> According to another survey by the Ministry of Health, Labour and Welfare in 2011, the greatest number of medications dispensed at community pharmacies was 21.9%, which were cardiovascular medications by therapeutic classification.<xref rid="b14-iprp-5-027" ref-type="bibr">14</xref> There are also studies that reported that the drugs most often prescribed over a long term were antilipemic medications and antihypertensive medications.<xref rid="b8-iprp-5-027" ref-type="bibr">8</xref>,<xref rid="b10-iprp-5-027" ref-type="bibr">10</xref> Another study reported that the examination of the management of hypertension in the elderly suggested that their blood pressure management was inadequate.<xref rid="b15-iprp-5-027" ref-type="bibr">15</xref></p><p>Because the intervention group had more opportunities to talk with the pharmacists than the control group, more information was obtained from the intervention group and their situations were better identified. Although most of the information identified was verified by the pharmacist and recorded with no action taken, guidance was provided when necessary, just as with regular medication guidance. The number of counseling sessions for incidents determined to be of high urgency and/or importance was greater in the intervention group than the control group. In fact, telephone counseling enabled early assistance in dealing with side effects, changes in physical condition, and urgent incidents caused by a lack of understanding in how to take medications. Additionally, the intervention group scored high for the item &#x0201c;the desire for treatment increased&#x0201d;, which indicates that changes in awareness and behavior may have improved medication adherence. The telephone counseling enabled regular and continuous assistance to resolve issues. It may also have assisted in resolution of issues, in addition to illnesses, that could not have been covered by on-site counseling alone.</p><p>At times it was difficult to identify the patient&#x02019;s situation as well as mental and physical conditions during telephone counseling, with some intervention group members withdrawing from telephone counseling. On the other hand, some patients went to the pharmacy for counseling on medications as well as for having their prescriptions filled, indicating that this study may have created an opportunity to discover that they could talk to their pharmacist any time they had questions. Treatment assistance with pharmacist participation during the prescription period may not only allow early response to issues, but also result in changes in attitude and behavior that lead to issue resolution.</p></sec><sec><title>Conclusion</title><p>In Japan, where prescriptions are not refilled, patients must always visit medical institutions to see physicians before receiving prescribed medications at pharmacies. For this reason, many patients do not feel the need to interact with pharmacists. Under these circumstances, days of medication administration lengthen year after year, with nobody being able to notice any changes in the patients for months. This study suggested that telephone counseling by pharmacists between physician visits might accelerate the resolution of patients&#x02019; issues, if only a little.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to express our sincere thanks to the pharmacists at the six pharmacies who participated in this study.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Disclosure</bold></p><p>The authors have no conflicts of interest to disclose.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-iprp-5-027"><label>1</label><element-citation publication-type="journal"><source>Ministry of Health, Labour and Welfare Notification</source><volume>73</volume><month>3</month><day>17</day><year>2000</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.mhlw.go.jp/topics/bukyoku/hoken/sinryou/02kokuji/dl/kokuji26a.pdf">http://www.mhlw.go.jp/topics/bukyoku/hoken/sinryou/02kokuji/dl/kokuji26a.pdf</ext-link></comment><date-in-citation>Accessed February 6, 2011</date-in-citation></element-citation></ref><ref id="b2-iprp-5-027"><label>2</label><element-citation publication-type="webpage"><source>Ministerial Ordinance Concerning National Health Insurance Act No 23</source><year>2002</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.mhlw.go.jp/topics/bukyoku/hoken/sinryou/02kokuji/dl/syourei1.pdf">http://www.mhlw.go.jp/topics/bukyoku/hoken/sinryou/02kokuji/dl/syourei1.pdf</ext-link></comment><date-in-citation>Accessed February 6, 2011</date-in-citation></element-citation></ref><ref id="b3-iprp-5-027"><label>3</label><element-citation publication-type="book"><source>Ministry of Health, Labour and Welfare, Trends of Health Expenditure of Community Pharmacy [webpage on the Internet]</source><publisher-loc>Japan</publisher-loc><publisher-name>Ministry of Health, Labour and Welfare</publisher-name><year>2014</year><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.mhlw.go.jp/bunya/iryouhoken/database/zenpan/cyouzai_doukou.html">http://www.mhlw.go.jp/bunya/iryouhoken/database/zenpan/cyouzai_doukou.html</ext-link></comment><date-in-citation>Accessed January 12, 2016</date-in-citation></element-citation></ref><ref id="b4-iprp-5-027"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamei</surname><given-names>M</given-names></name><name><surname>Onda</surname><given-names>M</given-names></name></person-group><article-title>Effects of deregulation on prescription term for outpatients&#x02019; drug therapy</article-title><source>Journal of Japan Society for Health Care Management</source><year>2003</year><volume>4</volume><issue>3</issue><fpage>377</fpage><lpage>383</lpage></element-citation></ref><ref id="b5-iprp-5-027"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onda</surname><given-names>M</given-names></name><name><surname>Kamei</surname><given-names>M</given-names></name></person-group><article-title>Impacts of deregulation of drug prescription term to the patient adherence</article-title><source>Japanese Journal of Social Pharmacy</source><year>2004</year><volume>23</volume><issue>1</issue><fpage>29</fpage><lpage>34</lpage><comment>Japanese</comment></element-citation></ref><ref id="b6-iprp-5-027"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onda</surname><given-names>M</given-names></name><name><surname>Kamei</surname><given-names>M</given-names></name><name><surname>Kono</surname><given-names>K</given-names></name></person-group><article-title>Impacts on the quality of medication service for outpatients and management of medical institutions by deregulation of drug prescription term</article-title><source>Japanese Journal of Health Economics and Policy</source><year>2004</year><volume>15</volume><fpage>5</fpage><lpage>22</lpage></element-citation></ref><ref id="b7-iprp-5-027"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Japan Pharmaceutical Association</collab></person-group><source>Working paper</source><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nichiyaku.or.jp/action/wp-content/uploads/2009/02/choukitouyaku.pdf">http://www.nichiyaku.or.jp/action/wp-content/uploads/2009/02/choukitouyaku.pdf</ext-link></comment><publisher-name>Japan Pharmaceutical Association</publisher-name><year>2009</year><date-in-citation>Accessed February 27, 2011</date-in-citation></element-citation></ref><ref id="b8-iprp-5-027"><label>8</label><element-citation publication-type="webpage"><source>Japan Medical Association Research Institute, Working paper No 225</source><year>2010</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.med.or.jp/etc/eq201103/hoken/110311eq140.pdf">http://www.med.or.jp/etc/eq201103/hoken/110311eq140.pdf</ext-link></comment><date-in-citation>Accessed February 27, 2011</date-in-citation></element-citation></ref><ref id="b9-iprp-5-027"><label>9</label><element-citation publication-type="webpage"><source>Pharmacists Act, Article 25-2</source><year>2013</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.japaneselawtranslation.go.jp/law/detail_main?re=01&#x00026;vm=04&#x00026;id=2596">http://www.japaneselawtranslation.go.jp/law/detail_main?re=01&#x00026;vm=04&#x00026;id=2596</ext-link></comment><date-in-citation>Acccessed September 1, 2015</date-in-citation></element-citation></ref><ref id="b10-iprp-5-027"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamei</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>S</given-names></name><name><surname>Muto</surname><given-names>M</given-names></name><name><surname>Iijima</surname><given-names>U</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name></person-group><article-title>A Study on the effectiveness of pharmaceutical care management to the elderly patients with chronic disease</article-title><source>Journal of Japan Society for Healthcare Administration</source><year>2007</year><volume>44</volume><fpage>144</fpage><comment>Japanese</comment></element-citation></ref><ref id="b11-iprp-5-027"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>RA</given-names></name><name><surname>Barber</surname><given-names>N</given-names></name><name><surname>Clifford</surname><given-names>S</given-names></name><name><surname>Horne</surname><given-names>R</given-names></name><name><surname>Hartley</surname><given-names>E</given-names></name></person-group><article-title>The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines</article-title><source>Pharm World Sci</source><year>2008</year><volume>30</volume><issue>1</issue><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">17557211</pub-id></element-citation></ref><ref id="b12-iprp-5-027"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Leung</surname><given-names>WY</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving poly-pharmacy: randomized controlled trial</article-title><source>BMJ</source><year>2006</year><volume>333</volume><issue>7567</issue><fpage>522</fpage><pub-id pub-id-type="pmid">16916809</pub-id></element-citation></ref><ref id="b13-iprp-5-027"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health, Labour and Welfare [homepage on the Internet]</collab></person-group><source>Summary of Patient Survey 2011</source><publisher-name>Ministry of Health, Labour and Welfare</publisher-name><year>2012</year><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.mhlw.go.jp/english/database/db-hss/sps_2011.html">http://www.mhlw.go.jp/english/database/db-hss/sps_2011.html</ext-link></comment><date-in-citation>Accessed January 12, 2016</date-in-citation></element-citation></ref><ref id="b14-iprp-5-027"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health, Labour and Welfare [homepage on the Internet]</collab></person-group><source>Estimates of National Medical Care Expenditure FY 2012</source><publisher-name>Ministry of Health, Labour and Welfare</publisher-name><year>2014</year><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.mhlw.go.jp/english/database/db-hss/enmce_2012.html">http://www.mhlw.go.jp/english/database/db-hss/enmce_2012.html</ext-link></comment><date-in-citation>Accessed January 12, 2016</date-in-citation></element-citation></ref><ref id="b15-iprp-5-027"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>Y</given-names></name><name><surname>Dobashi</surname><given-names>T</given-names></name><name><surname>Miyata</surname><given-names>E</given-names></name><name><surname>Onaka</surname><given-names>U</given-names></name></person-group><article-title>A study on the management status of elderly patients with hypertension</article-title><source>Journal of Blood Pressure</source><year>2008</year><volume>15</volume><issue>8</issue><fpage>712</fpage><lpage>715</lpage><comment>Japanese</comment></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-iprp-5-027" position="float"><label>Table 1</label><caption><p>Category of recorded items</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Category</th><th valign="top" align="left" rowspan="1" colspan="1">Description of examples</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Blood pressure</td><td valign="top" align="left" rowspan="1" colspan="1">Frequency of blood pressure measurement, time range, and reason; values of blood pressure and heart rate; and blood pressure condition</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Changes in physical condition</td><td valign="top" align="left" rowspan="1" colspan="1">Presence of changes in physical condition; symptoms; time; frequency; and actions taken</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Side effects</td><td valign="top" align="left" rowspan="1" colspan="1">Presence of suspicion (prescription medications, OTC drugs, and functional foods); symptoms; time, frequency; and actions taken</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Therapies and prescriptions</td><td valign="top" align="left" rowspan="1" colspan="1">Changes in prescriptions; changes in dosage and administration; therapy method; instructions from physician; and consultation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Medication compliance</td><td valign="top" align="left" rowspan="1" colspan="1">Presence, frequency, and reason of missed dosage, self-adjustment, accidental ingestion, or medication withdrawal; understanding of medication administration; and action to take for missed dosage</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Leftover medication</td><td valign="top" align="left" rowspan="1" colspan="1">Presence of excess and deficiency; cause and reason; amount of leftover medication; presence of adjustment of dates of prescription; expiration date; and disposal of medication</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Storage</td><td valign="top" align="left" rowspan="1" colspan="1">Presence of storage location for medication, and changes in quality of medication</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Examinations elsewhere</td><td valign="top" align="left" rowspan="1" colspan="1">Presence; number of examinations; specialty department names; and purpose and reason</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Concomitant medication</td><td valign="top" align="left" rowspan="1" colspan="1">Presence; names of prescription medications; start and end; time; and reason and purpose</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tests, surgeries</td><td valign="top" align="left" rowspan="1" colspan="1">Schedule; time; reason; necessity for medication withdrawal; and results. Includes dental extraction</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Treatment history</td><td valign="top" align="left" rowspan="1" colspan="1">History; medication history; and treatment history</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OTC drugs, functional foods</td><td valign="top" align="left" rowspan="1" colspan="1">Presence; time; symptoms; frequency; reason; process; and consultation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Interactions</td><td valign="top" align="left" rowspan="1" colspan="1">Intake of prescription medications, OTC drugs, functional foods, and regular foods (grapefruit juice) that might cause interactions; and process</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lifestyle, habits</td><td valign="top" align="left" rowspan="1" colspan="1">Diet and sodium intake; exercise; habits; favorite foods; work; trips; and consultation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Other</td><td valign="top" align="left" rowspan="1" colspan="1">Urgent care; plan to change hospitals; body weight; opinions about consultation; desire; and medication handbook</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-iprp-5-027"><p><bold>Abbreviation:</bold> OTC, over-the-counter medication.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-iprp-5-027" position="float"><label>Table 2</label><caption><p>Characteristics of participants at start of study</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="2" valign="top" align="left">Characteristics</th><th colspan="2" valign="top" align="left" rowspan="1">Control group
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Intervention group
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">n</th><th valign="top" align="left" rowspan="1" colspan="1">%</th><th valign="top" align="left" rowspan="1" colspan="1">n</th><th valign="top" align="left" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Totals</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">53</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td><td valign="top" align="left" rowspan="1" colspan="1">59</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="left" rowspan="1" colspan="1">21</td><td valign="top" align="left" rowspan="1" colspan="1">39.6%</td><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="left" rowspan="1" colspan="1">39.0%</td><td valign="top" align="left" rowspan="1" colspan="1">0.945<xref ref-type="table-fn" rid="tfn2-iprp-5-027">a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="left" rowspan="1" colspan="1">32</td><td valign="top" align="left" rowspan="1" colspan="1">60.4%</td><td valign="top" align="left" rowspan="1" colspan="1">36</td><td valign="top" align="left" rowspan="1" colspan="1">61.0%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="3" valign="top" align="left" colspan="1">Age</td><td valign="top" align="left" rowspan="1" colspan="1">60&#x02013;64</td><td valign="top" align="left" rowspan="1" colspan="1">16</td><td valign="top" align="left" rowspan="1" colspan="1">30.2%</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">32.2%</td><td valign="top" align="left" rowspan="1" colspan="1">0.560<xref ref-type="table-fn" rid="tfn2-iprp-5-027">a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">65&#x02013;69</td><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">28.3%</td><td valign="top" align="left" rowspan="1" colspan="1">21</td><td valign="top" align="left" rowspan="1" colspan="1">35.6%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">70&#x02013;74</td><td valign="top" align="left" rowspan="1" colspan="1">22</td><td valign="top" align="left" rowspan="1" colspan="1">41.5%</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">32.2%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Issuing institution</td><td valign="top" align="left" rowspan="1" colspan="1">Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">50</td><td valign="top" align="left" rowspan="1" colspan="1">94.3%</td><td valign="top" align="left" rowspan="1" colspan="1">50</td><td valign="top" align="left" rowspan="1" colspan="1">84.7%</td><td valign="top" align="left" rowspan="1" colspan="1">0.101<xref ref-type="table-fn" rid="tfn2-iprp-5-027">a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Clinic</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">5.7%</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">15.3%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="3" valign="top" align="left" colspan="1">Prescription length (days)</td><td valign="top" align="left" rowspan="1" colspan="1">14&#x02013;35</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">24.5%</td><td valign="top" align="left" rowspan="1" colspan="1">17</td><td valign="top" align="left" rowspan="1" colspan="1">28.8%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">36&#x02013;70</td><td valign="top" align="left" rowspan="1" colspan="1">26</td><td valign="top" align="left" rowspan="1" colspan="1">49.1%</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">49.2%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">71 or more</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">26.4%</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">22.0%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of prescriptions (ave &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">3.30&#x000b1;1.20</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">3.32&#x000b1;1.37</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">0.935<xref ref-type="table-fn" rid="tfn3-iprp-5-027">b</xref></td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Amlodipine</td><td valign="top" align="left" rowspan="1" colspan="1">Brand drug</td><td valign="top" align="left" rowspan="1" colspan="1">39</td><td valign="top" align="left" rowspan="1" colspan="1">73.6%</td><td valign="top" align="left" rowspan="1" colspan="1">42</td><td valign="top" align="left" rowspan="1" colspan="1">71.2%</td><td valign="top" align="left" rowspan="1" colspan="1">0.472<xref ref-type="table-fn" rid="tfn2-iprp-5-027">a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Generic</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">26.4%</td><td valign="top" align="left" rowspan="1" colspan="1">17</td><td valign="top" align="left" rowspan="1" colspan="1">28.8%</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p><bold>Notes:</bold></p></fn><fn id="tfn2-iprp-5-027"><label>a</label><p>Chi-square test;</p></fn><fn id="tfn3-iprp-5-027"><label>b</label><p>Student&#x02019;s <italic>t</italic>-test.</p></fn><fn id="tfn4-iprp-5-027"><p><bold>Abbreviations:</bold> ave, average; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-iprp-5-027" position="float"><label>Table 3</label><caption><p>Number of data items collected from counseling</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top" align="left" colspan="1"/><th colspan="3" valign="top" align="left" rowspan="1">Control group (n=53)
<hr/></th><th colspan="6" valign="top" align="left" rowspan="1">Intervention group (n=59)
<hr/></th></tr><tr><th colspan="3" valign="top" align="left" rowspan="1">At the pharmacy
<hr/></th><th colspan="3" valign="top" align="left" rowspan="1">At the pharmacy
<hr/></th><th colspan="3" valign="top" align="left" rowspan="1">By telephone
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Number of samples</th><th valign="top" align="left" rowspan="1" colspan="1">Ratio</th><th valign="top" align="left" rowspan="1" colspan="1">Number of samples per person</th><th valign="top" align="left" rowspan="1" colspan="1">Number of samples</th><th valign="top" align="left" rowspan="1" colspan="1">Ratio</th><th valign="top" align="left" rowspan="1" colspan="1">Number of samples per person</th><th valign="top" align="left" rowspan="1" colspan="1">Number of samples</th><th valign="top" align="left" rowspan="1" colspan="1">Ratio</th><th valign="top" align="left" rowspan="1" colspan="1">Number of samples per person</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Totals</td><td valign="top" align="left" rowspan="1" colspan="1">837</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td><td valign="top" align="left" rowspan="1" colspan="1">15.8</td><td valign="top" align="left" rowspan="1" colspan="1">935</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td><td valign="top" align="left" rowspan="1" colspan="1">15.8</td><td valign="top" align="left" rowspan="1" colspan="1">680</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td><td valign="top" align="left" rowspan="1" colspan="1">11.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Blood pressure</td><td valign="top" align="left" rowspan="1" colspan="1">126</td><td valign="top" align="left" rowspan="1" colspan="1">15.1%</td><td valign="top" align="left" rowspan="1" colspan="1">2.4</td><td valign="top" align="left" rowspan="1" colspan="1">147</td><td valign="top" align="left" rowspan="1" colspan="1">15.7%</td><td valign="top" align="left" rowspan="1" colspan="1">2.5</td><td valign="top" align="left" rowspan="1" colspan="1">86</td><td valign="top" align="left" rowspan="1" colspan="1">12.6%</td><td valign="top" align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Changes in physical condition</td><td valign="top" align="left" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">6.6%</td><td valign="top" align="left" rowspan="1" colspan="1">1.0</td><td valign="top" align="left" rowspan="1" colspan="1">66</td><td valign="top" align="left" rowspan="1" colspan="1">7.1%</td><td valign="top" align="left" rowspan="1" colspan="1">1.1</td><td valign="top" align="left" rowspan="1" colspan="1">82</td><td valign="top" align="left" rowspan="1" colspan="1">12.1%</td><td valign="top" align="left" rowspan="1" colspan="1">1.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Side effects</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">2.3%</td><td valign="top" align="left" rowspan="1" colspan="1">0.4</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">3.1%</td><td valign="top" align="left" rowspan="1" colspan="1">0.5</td><td valign="top" align="left" rowspan="1" colspan="1">41</td><td valign="top" align="left" rowspan="1" colspan="1">6.0%</td><td valign="top" align="left" rowspan="1" colspan="1">0.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Medication compliance</td><td valign="top" align="left" rowspan="1" colspan="1">77</td><td valign="top" align="left" rowspan="1" colspan="1">9.2%</td><td valign="top" align="left" rowspan="1" colspan="1">1.5</td><td valign="top" align="left" rowspan="1" colspan="1">85</td><td valign="top" align="left" rowspan="1" colspan="1">9.1%</td><td valign="top" align="left" rowspan="1" colspan="1">1.4</td><td valign="top" align="left" rowspan="1" colspan="1">72</td><td valign="top" align="left" rowspan="1" colspan="1">10.6%</td><td valign="top" align="left" rowspan="1" colspan="1">1.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Leftover medication</td><td valign="top" align="left" rowspan="1" colspan="1">81</td><td valign="top" align="left" rowspan="1" colspan="1">9.7%</td><td valign="top" align="left" rowspan="1" colspan="1">1.5</td><td valign="top" align="left" rowspan="1" colspan="1">92</td><td valign="top" align="left" rowspan="1" colspan="1">9.8%</td><td valign="top" align="left" rowspan="1" colspan="1">1.6</td><td valign="top" align="left" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">5.9%</td><td valign="top" align="left" rowspan="1" colspan="1">0.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Storage</td><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="left" rowspan="1" colspan="1">2.7%</td><td valign="top" align="left" rowspan="1" colspan="1">0.4</td><td valign="top" align="left" rowspan="1" colspan="1">16</td><td valign="top" align="left" rowspan="1" colspan="1">1.7%</td><td valign="top" align="left" rowspan="1" colspan="1">0.3</td><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">1.2%</td><td valign="top" align="left" rowspan="1" colspan="1">0.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Examinations elsewhere</td><td valign="top" align="left" rowspan="1" colspan="1">67</td><td valign="top" align="left" rowspan="1" colspan="1">8.0%</td><td valign="top" align="left" rowspan="1" colspan="1">1.3</td><td valign="top" align="left" rowspan="1" colspan="1">77</td><td valign="top" align="left" rowspan="1" colspan="1">8.2%</td><td valign="top" align="left" rowspan="1" colspan="1">1.3</td><td valign="top" align="left" rowspan="1" colspan="1">45</td><td valign="top" align="left" rowspan="1" colspan="1">6.6%</td><td valign="top" align="left" rowspan="1" colspan="1">0.8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Concomitant medication</td><td valign="top" align="left" rowspan="1" colspan="1">58</td><td valign="top" align="left" rowspan="1" colspan="1">6.9%</td><td valign="top" align="left" rowspan="1" colspan="1">1.1</td><td valign="top" align="left" rowspan="1" colspan="1">66</td><td valign="top" align="left" rowspan="1" colspan="1">7.1%</td><td valign="top" align="left" rowspan="1" colspan="1">1.1</td><td valign="top" align="left" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">5.9%</td><td valign="top" align="left" rowspan="1" colspan="1">0.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OTC drugs, functional foods</td><td valign="top" align="left" rowspan="1" colspan="1">44</td><td valign="top" align="left" rowspan="1" colspan="1">5.3%</td><td valign="top" align="left" rowspan="1" colspan="1">0.8</td><td valign="top" align="left" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">5.9%</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td><td valign="top" align="left" rowspan="1" colspan="1">42</td><td valign="top" align="left" rowspan="1" colspan="1">6.2%</td><td valign="top" align="left" rowspan="1" colspan="1">0.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Interactions</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">2.2%</td><td valign="top" align="left" rowspan="1" colspan="1">0.3</td><td valign="top" align="left" rowspan="1" colspan="1">22</td><td valign="top" align="left" rowspan="1" colspan="1">2.4%</td><td valign="top" align="left" rowspan="1" colspan="1">0.4</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">1.3%</td><td valign="top" align="left" rowspan="1" colspan="1">0.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lifestyle, habits</td><td valign="top" align="left" rowspan="1" colspan="1">149</td><td valign="top" align="left" rowspan="1" colspan="1">17.8%</td><td valign="top" align="left" rowspan="1" colspan="1">2.8</td><td valign="top" align="left" rowspan="1" colspan="1">155</td><td valign="top" align="left" rowspan="1" colspan="1">16.6%</td><td valign="top" align="left" rowspan="1" colspan="1">2.6</td><td valign="top" align="left" rowspan="1" colspan="1">113</td><td valign="top" align="left" rowspan="1" colspan="1">16.6%</td><td valign="top" align="left" rowspan="1" colspan="1">1.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Other</td><td valign="top" align="left" rowspan="1" colspan="1">120</td><td valign="top" align="left" rowspan="1" colspan="1">14.3%</td><td valign="top" align="left" rowspan="1" colspan="1">2.3</td><td valign="top" align="left" rowspan="1" colspan="1">125</td><td valign="top" align="left" rowspan="1" colspan="1">13.4%</td><td valign="top" align="left" rowspan="1" colspan="1">2.1</td><td valign="top" align="left" rowspan="1" colspan="1">102</td><td valign="top" align="left" rowspan="1" colspan="1">15.0%</td><td valign="top" align="left" rowspan="1" colspan="1">1.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Treatment</td><td valign="top" align="left" rowspan="1" colspan="1">49</td><td valign="top" align="left" rowspan="1" colspan="1">5.9%</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td><td valign="top" align="left" rowspan="1" colspan="1">50</td><td valign="top" align="left" rowspan="1" colspan="1">5.3%</td><td valign="top" align="left" rowspan="1" colspan="1">0.8</td><td valign="top" align="left" rowspan="1" colspan="1">29</td><td valign="top" align="left" rowspan="1" colspan="1">4.3%</td><td valign="top" align="left" rowspan="1" colspan="1">0.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Tests, surgeries</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">3.6%</td><td valign="top" align="left" rowspan="1" colspan="1">0.6</td><td valign="top" align="left" rowspan="1" colspan="1">36</td><td valign="top" align="left" rowspan="1" colspan="1">3.9%</td><td valign="top" align="left" rowspan="1" colspan="1">0.6</td><td valign="top" align="left" rowspan="1" colspan="1">32</td><td valign="top" align="left" rowspan="1" colspan="1">4.7%</td><td valign="top" align="left" rowspan="1" colspan="1">0.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Treatment history</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">2.3%</td><td valign="top" align="left" rowspan="1" colspan="1">0.4</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">1.2%</td><td valign="top" align="left" rowspan="1" colspan="1">0.2</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">2.1%</td><td valign="top" align="left" rowspan="1" colspan="1">0.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other</td><td valign="top" align="left" rowspan="1" colspan="1">22</td><td valign="top" align="left" rowspan="1" colspan="1">2.6%</td><td valign="top" align="left" rowspan="1" colspan="1">0.4</td><td valign="top" align="left" rowspan="1" colspan="1">28</td><td valign="top" align="left" rowspan="1" colspan="1">3.0%</td><td valign="top" align="left" rowspan="1" colspan="1">0.5</td><td valign="top" align="left" rowspan="1" colspan="1">27</td><td valign="top" align="left" rowspan="1" colspan="1">4.0%</td><td valign="top" align="left" rowspan="1" colspan="1">0.5</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-iprp-5-027"><p><bold>Abbreviation:</bold> OTC, over-the-counter medication.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-iprp-5-027" position="float"><label>Table 4</label><caption><p>Number of times guidance provided</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="top" align="left" rowspan="1">Control group (n=53)
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Intervention group (n=59)
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Guidance count</th><th valign="top" align="left" rowspan="1" colspan="1">Ratio</th><th valign="top" align="left" rowspan="1" colspan="1">Guidance count</th><th valign="top" align="left" rowspan="1" colspan="1">Ratio</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Totals</td><td valign="top" align="left" rowspan="1" colspan="1">157</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td><td valign="top" align="left" rowspan="1" colspan="1">450</td><td valign="top" align="left" rowspan="1" colspan="1">100.0%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">The incidents with priority needs</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">5.7%</td><td valign="top" align="left" rowspan="1" colspan="1">46</td><td valign="top" align="left" rowspan="1" colspan="1">10.2%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Confirmed problem resolution after guidance</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">1.9%</td><td valign="top" align="left" rowspan="1" colspan="1">25</td><td valign="top" align="left" rowspan="1" colspan="1">5.6%</td></tr></tbody></table></table-wrap><table-wrap id="t5-iprp-5-027" position="float"><label>Table 5</label><caption><p>Guidance for important items and number of resolved cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="top" align="left" rowspan="1">Control group
<hr/></th><th colspan="3" valign="top" align="left" rowspan="1">Intervention group
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Guidance at pharmacy</th><th valign="top" align="left" rowspan="1" colspan="1">Number resolved</th><th valign="top" align="left" rowspan="1" colspan="1">Guidance at pharmacy</th><th valign="top" align="left" rowspan="1" colspan="1">Guidance by telephone</th><th valign="top" align="left" rowspan="1" colspan="1">Number resolved</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Totals</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">37</td><td valign="top" align="left" rowspan="1" colspan="1">20</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Blood pressure</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Changes in physical condition</td><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Side effects</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Medication compliance</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Storage</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Examinations elsewhere</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Concomitant medication</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OTC drugs, functional foods</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lifestyle, habits</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Treatment, prescription</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">3</td></tr></tbody></table><table-wrap-foot><fn id="tfn6-iprp-5-027"><p><bold>Abbreviation:</bold> OTC, over-the-counter medication.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6-iprp-5-027" position="float"><label>Table 6</label><caption><p>Changes in awareness and behavior at end of study</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Control group<break/>(n=53)</th><th valign="top" align="left" rowspan="1" colspan="1">Intervention group<break/>(n=59)</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">I forget to take my medication less often</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">0.071</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I have a higher desire for treatment</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">0.023</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I do not wait as long to seek consultation about things I am worried or anxious about</td><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">0.431</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I started paying attention to what I eat</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">0.929</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I started exercising</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">0.071</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I started using a medicine journal</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">0.381</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I am now aware of the effects of taking other medicines with my medication</td><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">0.189</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I now feel I can ask the pharmacist about anything</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">0.623</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Other, no change</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">0.684</td></tr></tbody></table><table-wrap-foot><fn id="tfn7-iprp-5-027"><p><bold>Note:</bold> Chi-square test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>